Nordihydroguaiaretic acid inhibits transforming growth factor beta type 1 receptor activity and downstream signaling.
about
Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update.The insulin receptor: a new target for cancer therapy.Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1.mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.Inhibitory effect of nordihydroguaiaretic acid on β-catenin/Tcf signalling in β-catenin-activated cells.
P2860
Nordihydroguaiaretic acid inhibits transforming growth factor beta type 1 receptor activity and downstream signaling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@en
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@nl
type
label
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@en
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@nl
prefLabel
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@en
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@nl
P2093
P2860
P1476
Nordihydroguaiaretic acid inhi ...... vity and downstream signaling.
@en
P2093
Fusheng Li
Jack F Youngren
Johnny D Pham
Marc O Anderson
P2860
P356
10.1016/J.EJPHAR.2009.06.012
P407
P577
2009-06-17T00:00:00Z